What Is Nicotinamide Riboside?
Nicotinamide Riboside (NR) is a naturally occurring form of vitamin B3 found in trace amounts in milk, yeast, and some plant foods. It was identified as an NAD+ precursor by Dr. Charles Brenner's lab in 2004, and the patented form NIAGEN (by ChromaDex) has been the subject of extensive human clinical trials. NR is considered one of the two primary NAD+ precursor supplements alongside NMN (nicotinamide mononucleotide).
NAD+ (nicotinamide adenine dinucleotide) is a coenzyme present in every cell and essential for over 500 enzymatic reactions, including glycolysis, the citric acid cycle, oxidative phosphorylation, DNA repair, and cell signalling. Its decline with age is now understood as a key driver of the cellular dysfunction associated with aging.
Biochemical Pathway: How NR Becomes NAD+
NR enters cells via nucleoside transporters and is phosphorylated by NRK1 or NRK2 (nicotinamide riboside kinases) to form NMN (nicotinamide mononucleotide). NMN is then converted to NAD+ by NMNAT enzymes. This pathway is distinct from the NMN → NAD+ route, though they share the final step.
An important distinction: NR can also be converted to nicotinamide (NAM) in the gut or liver and enter NAD+ synthesis via the salvage pathway. This means some of NR's effect may be indirect, but the net result—elevated NAD+—is consistent across studies.
NMN must be converted to NR before entering most cells (via CD73 enzyme on cell surfaces), whereas NR enters cells directly. However, NMN has its own dedicated transporter (Slc12a8) in the gut and some tissues, potentially giving it direct cellular access. In practice, both raise NAD+ effectively. NR has more published human RCT data; NMN has more recent mechanistic evidence. Choose based on quality, cost, and personal response.
Clinical Evidence in Humans
| Study | Population | Dose / Duration | Outcome |
|---|---|---|---|
| Trammel et al. 2016 (Cell Metabolism) | Healthy adults | 100–300 mg, single dose | Dose-dependent NAD+ increase in blood; first human pharmacokinetic data |
| Martens et al. 2018 (Nat Comm) | Older adults (55–79) | 1000 mg/day, 6 weeks | +60% blood NAD+; improved mitochondrial function in muscle; reduced aortic stiffness trend |
| Elysium BASIS RCTs | Adults 60+ | 250 mg NR + 50 mg pterostilbene | Sustained NAD+ elevation; improved sleep quality in subset |
| Dollerup et al. 2018 | Obese men | 1000 mg/day, 12 weeks | Raised blood NAD+ but no change in insulin sensitivity—suggests NAD+ elevation alone insufficient for metabolic benefit |
| Mehmel et al. 2020 (review) | Meta-analysis | Various | Consistent NAD+ elevation across populations; safety confirmed |
Mechanisms and Downstream Benefits
Elevated NAD+ activates several longevity-associated pathways:
- Sirtuins (SIRT1–7): NAD+-dependent deacetylases that regulate gene expression, mitochondrial biogenesis (via PGC-1α), DNA repair, and inflammation. SIRT1 is particularly important for caloric restriction mimicry.
- PARP1/2: DNA repair enzymes that consume large amounts of NAD+. As DNA damage accumulates with age, PARP activity increases, depleting NAD+. NR helps replenish the pool.
- CD38: A major NADase enzyme whose activity increases with age, consuming NAD+. (Note: CD38 inhibitors like apigenin are increasingly used alongside NR/NMN to preserve NAD+ levels.)
- Mitochondrial Complex I: NAD+ is essential for NADH oxidation in the electron transport chain. NAD+ repletion supports mitochondrial respiration efficiency.
Dosing Protocols
- Conservative longevity: 300 mg/day in the morning
- Standard protocol: 500 mg/day
- Advanced / age-related decline: 1000 mg/day (split 500 mg AM + 500 mg midday)
- With pterostilbene (Basis formula): 250 mg NR + 50 mg pterostilbene
Take in the morning. NR has mild energising effects for some people. Taking with food slows absorption but does not significantly reduce efficacy. Avoid taking late evening.
Both NR and NMN work better when combined with TMG (trimethylglycine), which provides methyl groups consumed during NAD+ metabolism. When NAD+ is converted to nicotinamide and recycled, the methylation pathway is utilised, potentially depleting methyl donors. Taking 500–1000 mg TMG alongside NR/NMN is now standard practice. Apigenin (50–100 mg) inhibits CD38, the enzyme that degrades NAD+, further amplifying NR's effect.
Safety and Side Effects
NR has an excellent safety profile confirmed by multiple human trials:
- No serious adverse events reported in clinical doses (up to 2000 mg/day in studies)
- NR does not cause the flushing associated with high-dose niacin (nicotinic acid)
- Occasional reports of mild GI discomfort, nausea, or headache at high doses
- Some concern about NR potentially promoting certain cancer cell growth (NAD+ is also consumed by rapidly dividing cells)—this remains theoretical; current evidence does not support avoidance in cancer, but patients should consult oncologists
- No established interactions with common medications
Frequently Asked Questions
NR vs NMN – which should I take in India?
Both raise NAD+ effectively. NR (NIAGEN) has more published human RCT data confirming NAD+ elevation (40–90% increase). NMN has more recent mechanistic research and dedicated gut transporter data. Cost-wise, NMN tends to be cheaper on Indian supplement platforms. If budget allows, NIAGEN (branded NR) offers more clinical certainty. Both should be taken with TMG to support methylation. A combined low-dose approach (300 mg NR + 300 mg NMN) is used by some biohackers but has not been formally studied.
What is NIAGEN and how is it dosed?
NIAGEN is the patented, clinically-studied form of nicotinamide riboside made by ChromaDex. It is the NR used in published human RCTs. Doses studied: 100 mg, 300 mg, and 1000 mg/day, with 300–1000 mg being the therapeutic range. At 1000 mg, blood NAD+ increases ~60% in older adults with improvements in muscle mitochondrial function. Start at 300 mg and increase based on response and budget.
Does NR actually increase NAD+ in humans?
Yes—definitively established. Multiple human RCTs confirm oral NR raises blood NAD+ by 40–90% at doses of 300–1000 mg/day. The Trammel et al. 2016 and Martens et al. 2018 studies are landmark publications confirming this in peer-reviewed journals. Tissue NAD+ (muscle, liver) also increases, though measuring this requires biopsy and is less commonly studied.
What are the longevity benefits of NR supplementation?
NAD+ declines ~50% between ages 40 and 60. Restoring NAD+ via NR activates sirtuins (SIRT1–7) and PARP enzymes involved in DNA repair, mitochondrial biogenesis, and cellular stress response. Human studies show improvements in muscle mitochondrial function, blood pressure, and potential neuroprotection. Direct longevity (lifespan extension) data exists only in animals; human longevity trials are ongoing. Mechanistic evidence is strong enough to justify use in an evidence-based longevity stack.